Evidence map›Paper›PMID 27377701›Full record

ArticleScientific reports2016

Smyd5 plays pivotal roles in both primitive and definitive hematopoiesis during zebrafish embryogenesis.

Tomoaki Fujii, Shin-Ichiro Tsunesumi, Hiroshi Sagara, Miyo Munakata, Yoshihiro Hisaki, Takao Sekiya, Yoichi Furukawa, Kazuhiro Sakamoto, Sumiko Watanabe

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Zebrafish: a convenient tool for myelopoiesis research.Cell regeneration (London, England) · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Zoological research · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tomoaki FujiiDepartment of Cancer Genome Research, Sasaki Institute, Sasaki Foundation, Tokyo 101-0062, Japan.
Shin-Ichiro TsunesumiDivision of Clinical Genome Research, Advanced Clinical Research Center, The University of Tokyo, Tokyo 108-8639, Japan.
Hiroshi SagaraFine Morphological Analysis Group Medical Proteomics Laboratory Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Miyo MunakataDepartment of Cancer Genome Research, Sasaki Institute, Sasaki Foundation, Tokyo 101-0062, Japan.
Yoshihiro HisakiDepartment of Cancer Genome Research, Sasaki Institute, Sasaki Foundation, Tokyo 101-0062, Japan.
Takao SekiyaDepartment of Cancer Genome Research, Sasaki Institute, Sasaki Foundation, Tokyo 101-0062, Japan.
Yoichi FurukawaDivision of Clinical Genome Research, Advanced Clinical Research Center, The University of Tokyo, Tokyo 108-8639, Japan.
Kazuhiro SakamotoDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo 113-8421, Japan.
Sumiko WatanabeDivision of Molecular and Developmental Biology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
The University of Tokyo · JPSasaki Institute · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylation of histone tails plays a pivotal role in the regulation of a wide range of biological processes. SET and MYND domain-containing protein (SMYD) is a methyltransferase, five family members of which have been identified in humans. SMYD1, SMYD2, SMYD3, and SMYD4 have been found to play critical roles in carcinogenesis and/or the development of heart and skeletal muscle. However, the physiological functions of SMYD5 remain unknown. To investigate the function of Smyd5 in vivo, zebrafish were utilised as a model system. We first examined smyd5 expression patterns in developing zebrafish embryos. Smyd5 transcripts were abundantly expressed at early developmental stages and then gradually decreased. Smyd5 was expressed in all adult tissues examined. Loss-of-function analysis of Smyd5 was then performed in zebrafish embryos using smyd5 morpholino oligonucleotide (MO). Embryos injected with smyd5-MO showed normal gross morphological development, including of heart and skeletal muscle. However, increased expression of both primitive and definitive hematopoietic markers, including pu.1, mpx, l-plastin, and cmyb, were observed. These phenotypes of smyd5-MO zebrafish embryos were also observed when we introduced mutations in smyd5 gene with the CRISPR/Cas9 system. As the expression of myeloid markers was elevated in smyd5 loss-of-function zebrafish, we propose that Smyd5 plays critical roles in hematopoiesis.

Indexed as

Embryonic DevelopmentHematopoiesisAnimalsBiomarkersCell LineageEmbryo, NonmammalianGene Expression ProfilingGene Expression Regulation, DevelopmentalGene Knockdown TechniquesHeartMethyltransferasesMorpholinosMuscle DevelopmentMyelopoiesisZebrafishZebrafish ProteinsBiomarkersMethyltransferasesMorpholinosSmyd5 protein, zebrafishZebrafish Proteins

Identifiers

PMID27377701
PMCPMC4932602
OpenAlexW2465979592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.